Holmusk announced today that it has entered a three-year collaboration with Otsuka Pharmaceutical Development & Commercialization, Inc. (Otsuka).

Together, Holmusk and Otsuka will work to drive a deeper understanding of unmet patient needs and real-world outcomes by employing proprietary analytics and artificial intelligence (AI) on multiple real-world data sources. These insights can have application across Otsuka’s portfolio and have the potential to improve patient lives. The new collaboration, worth up to $4 million annually, marks an expansion of the existing relationship that started with an exploration of real-world outcomes in behavioral health in 2020.

Find out more on Holmusk’s collaboration with Otsuka on the company’s press release.